Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hampson, Lisa V
211  Ergebnisse:
Personensuche X
?
1

Assurance methods for designing a clinical trial with a del..:

Salsbury, James A. ; Oakley, Jeremy E. ; Julious, Steven A..
Statistics in Medicine.  43 (2024)  19 - p. 3595-3612 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Monitoring Overall Survival in Pivotal Trials in Indolent C..:

Fleming, Thomas R. ; Hampson, Lisa V. ; Bharani-Dharan, Bharani...
Statistics in Biopharmaceutical Research.  , 2024
Link: https://doi.org/10.1080/..
 
?
3

Innovative Hybrid Designs and Analytical Approaches Leverag..:

, In: Real-World Evidence in Medical Product Development,
Hampson, Lisa V. ; Izem, Rima - p. 211-232 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Combining the Target Trial and Estimand Frameworks to Defin..:

Hampson, Lisa V. ; Chu, Jufen ; Zia, Aiesha...
Statistics in Biopharmaceutical Research.  16 (2023)  1 - p. 1-10 , 2023
Link: https://doi.org/10.1080/..
 
?
5

Eliciting judgements about dependent quantities of interest..:

Holzhauer, Björn ; Hampson, Lisa V. ; Gosling, John Paul...
Pharmaceutical Statistics.  21 (2022)  5 - p. 1005-1021 , 2022
Link: https://doi.org/10.1002/..
 
?
6

Improving the assessment of the probability of success in l..:

Hampson, Lisa V. ; Bornkamp, Björn ; Holzhauer, Björn...
Pharmaceutical Statistics.  21 (2021)  2 - p. 439-459 , 2021
Link: https://doi.org/10.1002/..
 
?
7

Group Sequential and Adaptive Designs:

, In: Handbook of Multiple Comparisons,
Glimm, Ekkehard ; Hampson, Lisa V. - p. 235-268 , 2021
Link: https://doi.org/10.1201/..
 
?
8

Bridging across patient subgroups in phase I oncology trial..:

Zheng, Haiyan ; Hampson, Lisa V ; Jaki, Thomas
Statistical Methods in Medical Research.  30 (2021)  4 - p. 1057-1071 , 2021
Link: https://doi.org/10.1177/..
 
?
9

Study to evaluate the optimal dose of remifentanil required..:

Arnold, Philip ; Sanaulla, Syed ; Hampson, Lisa V....
Pediatric Anesthesia.  31 (2021)  5 - p. 548-556 , 2021
Link: https://doi.org/10.1111/..
 
?
10

Mycophenolate Mofetil Versus Cyclophosphamide for Remission..:

Brogan, Paul A. ; Arch, Barbara ; Hickey, Helen...
Arthritis & Rheumatology.  73 (2021)  9 - p. 1673-1682 , 2021
Link: https://doi.org/10.1002/..
 
?
11

Comment on "Biostatistical Considerations When Using RWD an..:

Hampson, Lisa V. ; Degtyarev, Evgeny ; Tang, Rui (Sammi)...
Statistics in Biopharmaceutical Research.  , 2021
Link: https://doi.org/10.1080/..
 
?
12

A New Comprehensive Approach to Assess the Probability of S..:

Hampson, Lisa V. ; Holzhauer, Björn ; Bornkamp, Björn...
Clinical Pharmacology & Therapeutics.  111 (2021)  5 - p. 1050-1060 , 2021
Link: https://doi.org/10.1002/..
 
?
13

Exposure–response modelling approaches for determining opti..:

Wadsworth, Ian ; Hampson, Lisa V ; Bornkamp, Björn.
Statistical Methods in Medical Research.  29 (2020)  9 - p. 2583-2602 , 2020
Link: https://doi.org/10.1177/..
 
?
14

A Bayesian decision‐theoretic approach to incorporate precl..:

Zheng, Haiyan ; Hampson, Lisa V.
Biometrical Journal.  62 (2020)  6 - p. 1408-1427 , 2020
Link: https://doi.org/10.1002/..
 
?
15

Response to comments on Jaki et al., a proposal for a new P..:

Jaki, Thomas ; Forster, Pamela ; Bijens, Luc.... (2019)  3 - p. 284-286
Link: https://doi.org/10.1002/..
 
1-15